All values are in Canadian dollars.
CALGARY, Feb. 9, 2012 /PRNewswire/ - Provident Energy Ltd. (Provident) (TSX-PVE; NYSE-PVX) announced today its 2011 U.S. Shareholder Tax Information.
Provident is treated as a corporation for U.S. federal income tax purposes. As a corporation, Provident's dividends to U.S. shareholders may be "qualified dividends" as determined under the U.S. Internal Revenue Code.
Provided the dividends received by U.S. resident shareholders in 2011 are considered to be qualified dividends as noted above, 100 percent of the dividends should be reported as "qualified dividends" with 0 percent being reported as tax deferred return of capital.
To assist with the preparation of 2011 U.S. tax information, non-registered U.S. shareholders should receive a Form 1099-DIV from their broker or intermediary. Provident's transfer agent, Computershare Trust Company, will issue a Form 1099-DIV to all registered U.S. shareholders.
Dividends paid to non-residents of Canada were subject to withholding tax at a minimum of fifteen percent, which was withheld prior to the dividends being paid to the shareholder. Dividends after January 2011, paid into a U.S. qualified retirement account should not be subject to any withholding taxes. Information regarding the amount of Canadian tax withheld in 2011 should be determined from your own records and is not available from Provident.
Tax information pertaining to 2011 and prior years is available on Provident's website at: http://www.providentenergy.com/investor/taxinfo.cfm.
The summary contained in this news release is of a general nature only and does not constitute and is not intended to be legal or tax advice to any particular holder or potential holder of Provident shares (units prior to January 1, 2011). Holders or potential holders of Provident shares are urged to consult their own legal and tax advisors as to their particular income tax consequences of holding Provident shares.
Provident Energy Ltd. is a Calgary-based corporation that owns and manages a natural gas liquids (NGL) infrastructure and logistics business. Provident's facilities are strategically located in Western Canada and in the premium NGL markets in Eastern Canada and the U.S. Provident provides monthly cash dividends to its shareholders and trades on the Toronto Stock Exchange and the New York Stock Exchange under the symbols PVE and PVX, respectively.
This news release contains certain forward-looking statements concerning Provident, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, results of operations or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Provident's control, including the impact of general economic conditions in Canada and the United States, industry conditions, changes in laws and regulations including the adoption of new environmental laws and regulations and changes in how they are interpreted and enforced, increased competition, the lack of availability of qualified personnel or management, pipeline design and construction, fluctuations in commodity prices, foreign exchange or interest rates, stock market volatility and obtaining required approvals of regulatory authorities. Such forward-looking information is provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes, such as making investment decisions.
Such forward-looking statements or information are based on a number of assumptions which may prove to be incorrect. In addition to other assumptions identified in this news release, assumptions have been made regarding, among other things, commodity prices, operating conditions, capital and other expenditures, and project development activities.
Although Provident believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Provident can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Provident and described in the forward-looking statements or information.
The forward-looking statements or information contained in this news release are made as of the date hereof and Provident undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
SOURCE Provident Energy Ltd.
NEW YORK, Feb. 9, 2012 /PRNewswire/ -- JetBlue Airways Corporation (Nasdaq: JBLU) announced today that it will webcast a presentation given by JetBlue's leadership team on February 15, 2012. The webcast will begin at approximately 8:30 a.m. ET and is expected to run until 12:00 noon ET. Â
A live, listen-only webcast will be available on JetBlue's investor relations website at the following web address:
For those unable to listen to the live webcast, a replay will be available at the website address above.
JetBlue is New York's Hometown Airline(TM) with other focus cities in Boston, Fort Lauderdale, Los Angeles, and Orlando. Known for its award-winning service and free TV as much as its low fares, JetBlue offers the most legroom in coach of any U.S. airline (based on average fleet-wide seat pitch) as well as super-spacious Even More Space seats. JetBlue is also America's first and only airline to offer its own Customer Bill of Rights, with meaningful and specific compensation for customers inconvenienced by service disruptions within JetBlue's control. Visit www.jetblue.com/promise for details. JetBlue serves 70 cities with 700 daily flights with new service to Dallas/Fort Worth launching later this year. With JetBlue, all seats are assigned, all fares are one-way, and an overnight stay is never required. For information or reservations call 1-800-JET-BLUE (1-800-538-2583), TTY/TDD 1-800-336-5530, or visit www.jetblue.com.
Â
SOURCE JetBlue Airways Corporation
OLD GREENWICH, Conn., Feb. 9, 2012 /PRNewswire/ --Â Ellington Financial LLC (NYSE: EFC) (the "Company") today announced that its Board of Directors has declared a fourth quarter 2011 dividend of $0.40 per share, payable on March 15, 2012 to shareholders of record as of March 1, 2012(1). The Company's present intention is to pay quarterly and special dividends so that at least 100% of the Company's net income each calendar year has been distributed prior to April of the subsequent calendar year, subject to potential adjustments for changes in common shares outstanding. In May 2011, the Company's management announced that it expected to continue to recommend dividends of $0.40 per common share each quarter together with any potential special dividends to be declared following the end of each fiscal year as may be necessary to meet the Company's targeted 100% payout ratio. Periodically, management may adjust its quarterly dividend recommendation based on the Company's actual earnings, management's assessment of the Company's long-term earnings prospects, and other factors. The declaration and amount of future dividends remain in the discretion of the Board of Directors.
(1) For U.S. federal income tax purposes, the fourth quarter 2011 dividend will be treated as a partnership distribution. Based on information currently available, the Company estimates that, when calculating U.S. federal withholding taxes, the entire amount of this dividend will be treated as portfolio interest income (as described in Section 871(h) of the Internal Revenue Code). As a result, no portion of this dividend should be considered attributable to income that is subject to U.S. federal withholding tax, including U.S. source dividend income or income effectively connected with a U.S. trade or business. Notwithstanding the foregoing, some portion of future dividends may be considered attributable to U.S. source dividend income, interest income that is not "portfolio interest," or income effectively connected with a U.S. trade or business, and therefore may be subject to U.S. federal withholding taxes.
The Company does not provide advice on tax matters to its shareholders or to broker/nominees who hold the Company's shares on behalf of their customers. The information above is provided for information purposes only, is subject to change as more definitive information is obtained by the Company, and does not constitute tax advice. Non-U.S. holders of the Company's common shares and broker/nominees who hold shares on behalf of such holders are strongly urged to consult with their own tax advisors with regard to the U.S. federal income tax consequences of the dividends paid by the Company. This information is not intended to, and cannot, be used by any taxpayer to avoid penalties that may be imposed under U.S. federal income tax law.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from our beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as "anticipate," "estimate," "will," "should," "may," "expect," "believe," "intend," "seek," "plan" and similar expressions or their negative forms, or by references to strategy, plans, or intentions. Examples of forward-looking statements in this press release include statements regarding the Company's intended dividend policy. The Company's results can fluctuate from month to month and from quarter to quarter depending on a variety of factors, some of which are beyond the Company's control and/or are difficult to predict, including, without limitation, changes in interest rates and the market value of the Company's securities, changes in mortgage default rates and prepayment rates, the Company's ability to borrow to finance its assets, changes in government regulations affecting the Company's business, the Company's ability to maintain its exemption from registration under the Investment Company Act of 1940 and other changes in market conditions and economic trends. Furthermore, forward-looking statements are subject to risks and uncertainties, including, among other things, those described under Item 1A of our Annual Report on Form 10-K filed on March 16, 2011 and under Item 1A of our Quarterly Report on Form 10-Q filed on November 9, 2011, which can be accessed through the Company's website at www.ellingtonfinancial.com or at the SEC's website (www.sec.gov). Other risks, uncertainties, and factors that could cause actual results to differ materially from those projected may be described from time to time in reports we file with the SEC, including reports on Forms 10-Q, 10-K and 8-K. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
About Ellington Financial LLC
Ellington Financial LLC is a specialty finance company that acquires and manages mortgage-related assets, including residential mortgage-backed securities backed by prime jumbo, Alt-A and subprime residential mortgage loans, residential mortgage-backed securities for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, mortgage-related derivatives, commercial mortgage-backed securities, commercial mortgage loans and other commercial real estate debt, as well as corporate debt and equity securities and derivatives. Ellington Financial LLC is externally managed and advised by Ellington Financial Management LLC, an affiliate of Ellington Management Group LLC.Â
Â
SOURCE Ellington Financial LLC
WASHINGTON, Feb. 9, 2012 /PRNewswire-USNewswire/ -- Two leaders whose efforts in peace-building and conflict resolution have had an extraordinary impact on the international community will speak at the annual conference of NAFSA: Association of International Educators in May. Nobel Peace Prize Laureate Leymah Gbowee of Liberia, and Ambassador Jan Eliasson, distinguished diplomat, humanitarian, and former president of the United Nations General Assembly, will address 8,000 attendees from more than 120 countries at the NAFSA conference, taking place this year in Houston. The conference is the world's largest gathering of professionals in international education.
Liberian peace activist Leymah Gbowee is one of three outstanding women leaders who were awarded the 2011 Nobel Peace Prize "for their non-violent struggle for the safety of women and for women's rights to full participation in peace-building work." During Liberia's second civil war, Gbowee worked tirelessly across religious and ethnic lines to organize a peace movement of thousands of women who held nonviolent demonstrations in Monrovia. This movement became known as the Women of Liberia Mass Action for Peace, with Gbowee as the chief spokeswoman and leader. Its efforts are documented in her memoir, "Mighty Be Our Powers: How Sisterhood, Prayer, and Sex Changed a Nation at War," and in the award-winning 2008 film "Pray the Devil Back to Hell." (See Gbowee's interview about these works with Jon Stewart on "The Daily Show.") The movement continued to wage influence in Ghana during the peace-talk process and was a driving force behind the 2005 election as Liberian president of Ellen Johnson Sirleaf – the first elected woman leader of an African country and a co-recipient of the 2011 Nobel Peace Prize. Gbowee is founder and president of the recently established Gbowee Peace Foundation Africa, which aims to help women and girls become leaders in building and sustaining peace and security. She is also head of the Liberia Reconciliation Initiative, executive director of the Women Peace and Security Network Africa, and a founding member and former coordinator of the Women in Peacebuilding Program/West African Network for Peacebuilding. She is the Newsweek Daily Beast's Africa columnist and a member of the African Women Leaders Network for Reproductive Health and Family Planning. Gbowee will address NAFSA conference attendees on Wednesday, May 30, at the George R. Brown Convention Center in Houston.
A veteran diplomat and human rights advocate, Ambassador Jan Eliasson is chairman of WaterAid Sweden, the Swedish arm of an international nonprofit organization dedicated to improving access to safe water, hygiene, and sanitation for people in the world's poorest communities. He is also a member of the UN Secretary-General's Millennium Development Goals Advocacy Group, which is charged with galvanizing support for the achievement of the eight goals world leaders agreed to meet by 2015 in an effort to end global poverty. In the course of his distinguished career, Eliasson has served in some of the highest levels of the United Nations. From 1988 to 1992 he was Sweden's ambassador to the United Nations, where he was part of the UN mediation missions in the war between Iran and Iraq. In 1992, he became the first UN under-secretary-general for humanitarian affairs, leading efforts on landmines, conflict prevention, and other humanitarian actions in Somalia, Sudan, Mozambique and the Balkans. Eliasson was Sweden's state secretary for foreign affairs from 1994 to 2000 and the Swedish ambassador to the United States from 2000 to 2005. From 2005 to 2006, he served as president of the UN General Assembly. Eliasson's distinguished career as a Swedish diplomat culminated in his service as minister for foreign affairs, during which he played a key role in the evacuation of more than 8,000 Swedish citizens from Lebanon in 2006. From 2007 to 2008, Eliasson was the UN secretary-general's special envoy for Darfur. He will address NAFSA conference attendees on Friday, June 1, at the George R. Brown Convention Center in Houston.
Conference Highlights
- The NAFSA conference, the world's largest gathering of professionals in international education, is anchored by daily plenary events from Tuesday, May 29, through Friday, June 1. In addition to Leymah Gbowee and Jan Eliasson, NAFSA is honored to welcome former U.S. Secretary of Defense Robert Gates as the opening plenary speaker for the conference. Gates will speak to attendees on Tuesday, May 29. Learn more about the conference plenary lineup at www.nafsa.org/ac12plenaries.
- Get caught up on all the latest in international education at more than 200 concurrent sessions. Complete topic and panelist information will be online March 1.
- Explore the sights and sounds of the NAFSA Expo Hall, which features exhibitors representing hundreds of organizations from around the world, including colleges and universities, study abroad and intensive-English programs, embassies and government agencies, and more.
- Information about travel, housing, and much more will be online March 1 on our conference pages at www.nafsa.org/houston.
Media registration begins in March. To request an application, contact Katie O'Connell at katieo@nafsa.org.
With nearly 10,000 members, NAFSA: Association of International Educators is the world's largest nonprofit professional association dedicated to international education. Visit us at www.nafsa.org and www.ConnectingOurWorld.org.
Â
Â
Â
SOURCE NAFSA: Association of International Educators
SAN MATEO, Calif., Feb. 9, 2012 (GLOBE NEWSWIRE) -- NeurogesX (Nasdaq: NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced that the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to the U.S. Food and Drug Administration (FDA) did not recommend FDA approval of a new indication for Qutenza® (Capsaicin) 8% patch for the management of neuropathic pain (nerve pain) related to HIV associated peripheral neuropathy (HIV-PN).
While the FDA will consider recommendations of the Committee, the decision regarding the approval of a new indication is determined by the FDA. Currently, the Company's supplemental new drug application (sNDA) remains under evaluation, with Priority Review status granted by the FDA. A decision from the Agency is expected by March 7, 2012, under the Prescription Drug User Fee Act (PDUFA). Â
The Committee's recommendation followed today's presentations by the Company and the FDA. The Committee reviewed the efficacy and safety data from clinical studies of Qutenza® in the management of pain associated with HIV-PN.
"We will continue to work closely with the FDA to address the Advisory Committee's comments as the Agency finalizes its review of our sNDA," said Ronald Martell, CEO and President of NeurogesX. "We remain confident that Qutenza® has the potential to address significant, unmet medical needs and to improve the quality of life for patients with HIV-PN. We would like to thank the FDA and the Advisory Committee members for their careful and thoughtful deliberation on this matter."
About HIV-PN
HIV-PN is the most common neurological complication of HIV infection; researchers believe peripheral neuropathy is the driving force behind up to half of pain clinic visits among HIV patients1. Many patients with HIV are afflicted with symptoms ranging from mild tingling to severe and excruciating pain. HIV-PN is thought to be caused by multiple factors related to HIV infection including, injury of sensory neurons by HIV virus proteins, the immune system's fight against HIV and some antiretroviral drugs.
There is currently no FDA-approved or standard-of-care treatment for pain associated with HIV-PN.
In the United States, there are an estimated 1.2 million people infected with HIV2. The prevalence of HIV-PN remains high with use of combination anti-retroviral therapy, with an estimated 140,000 individuals in need of pain management intervention3.
About Qutenza®
Qutenza® (capsaicin) 8% patch, containing a prescription strength capsaicin, is approved by the U.S. Food and Drug Administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia (PHN). Qutenza® is also approved in the European Union and is marketed by Astellas Pharma Europe Ltd. (Astellas), the European affiliate of Tokyo-based Astellas Pharma Inc.
Clinical studies have shown that a single one-hour Qutenza® application can provide three months relief from pain associated with postherpetic neuralgia (PHN), the nerve pain that can occur after shingles.
In clinical trials, serious adverse reactions included application-associated pain and increase in blood pressure. The most common treatment-emergent adverse reactions (greater than or equal to five percent of Qutenza® patients and greater than control) were application-site erythema, application-site pain, application-site pruritus, and application-site papules.
For full Patient Information, visit http://www.qutenza.com/
For full Prescribing Information, visit http://www.qutenza.com/_docs/qutenza_full_PI_.pdf
About NeurogesX, Inc.
NeurogesX, Inc. (Nasdaq: NGSX) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improving patients' quality of life. Â
The Company's lead product, Qutenza® is currently approved in the United States and the European Union. Qutenza® is now available in the United States for the management of neuropathic pain associated with postherpetic neuralgia (PHN). In Europe, Qutenza® is being marketed by Astellas Pharma Europe Ltd. (Astellas), the European affiliate of Tokyo-based Astellas Pharma Inc., for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain.
The Company's most advanced product candidate, NGX-1998, is a Phase 3 ready, topically applied liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions such as PHN. NGX-1998 has completed three Phase 1 clinical trials and one Phase 2 clinical trial in PHN patients.
The Company's early-stage pipeline includes pre-clinical compounds which include a number of prodrugs of acetaminophen. The Company has evaluated certain of these compounds in vitro and in vivo.
Safe Harbor Statement
This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the Act). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include but are not limited to statements regarding: the timing and potential outcome of any FDA review of such sNDA, notwithstanding the March 7, 2012 PDUFA date; the scope and size of the potential market for Qutenza in the treatment of pain associated with HIV-PN; and the potential benefits of Qutenza®. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: difficulties or delays in the further development of Qutenza® for additional indications, including difficulties or delays in receipt of FDA approval of the sNDA to expand the U.S. label for Qutenza® for the management of pain due to HIV-PN; market acceptance of Qutenza® in already approved indications may not be sufficient to support further pursuit of an expanded label for Qutenza®, including as a result of physician or patient reluctance to use Qutenza®; Qutenza® and NeurogesX' other product candidates may have unexpected adverse side effects; unexpected or increased expenses in the commercialization and continued development of Qutenza® or the development of NGX-1998; and developments concerning or introduction by others of competitive products or therapies for the treatment or prevention of pain associated with HIV-PN. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.
1.   Verma S, et al. HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs. 2005;19:325-334.
2.   CDC. HIV surveillance – United States, 1981- 2008. MMWR 2011;60: 689-693
3.   Ellis. HIV and antiretroviral therapy: impact on the central nervous system. Prog Neurobiol. 2010; 91(2):185-7
CONTACT: NeurogesX, Inc.
Stephen Ghiglieri
Executive Vice President, COO and CFO (650) 358-3310
sghiglieri@neurogesx.com
The Ruth Group
Stephanie Carrington (investors)
(646) 536-7017
scarrington@theruthgroup.com
Victoria Aguiar (media)
(646) 536-7013
vaguiar@theruthgroup.com
Source: NeurogesX
More Press Releases
View Older Stories-
Homeownership Preservation Foundation Applauds State Attorneys General Settlement with Mortgage Servicers; Releases Statement on "Significant Victory" for Distressed Homeowners
-
Centerra Gold Updates Reserves and Resources Total Gold Reserves 8.1 million Contained Ounces
-
Atkore International Holdings Inc. Announces Fiscal Year 2012 First Quarter Results
-
Final Rosters Unveiled for the 2012 McDonald's All American® Games
-
PYA Launches Technology & Entrepreneurial Initiative
-
Flowers Foods Reports Fourth Quarter and Fiscal 2011 Results; Provides Guidance for 2012
-
Centerra Gold Updates Reserves and Resources Total Gold Reserves 8.1 million Contained Ounces
-
Invacare Corporation Announces Appointment of Ellen O’Kane Tauscher as New Independent Director
-
Array BioPharma to Present at the Leerink Swann Global Healthcare Conference
-
First Security Group Completes Transformation of Executive Management Team
-
REMINDER: Buckeye Partners, L.P. to Release Earnings and Hold Conference Call for 2011 Fourth-Quarter and Full Year Results
-
MCRA Hires Former Commercial Insurance Medical Director to Guide Firm's Reimbursement Strategies
-
Sandvik Coromant Extends Partnership With Stewart-Haas Racing
-
Partners Real Estate Investment Trust (TSX VENTURE: PAR.UN) Revises Payment Date of Previously Announced January Distribution of $0.01333 Per Unit
-
Partners Real Estate Investment Trust (TSX VENTURE:PAR.UN) Revises Payment Date of Previously Announced January Distribution of $0.01333 Per Unit
-
2011 Brings Second Highest Visitor Count in Las Vegas History, Record Targeted in 2012
-
Critical Mass Uses Kinect for Windows to Give Chicago Auto Show Attendees a First-Hand Experience of the 2013 Nissan Pathfinder Concept
-
Fitch Releases Report on San Miguel Electric Cooperative, Inc., TX
-
Romance Is in the Air at Hotel in Philadelphia
-
US Labor Department's Office of Disability Employment Policy releases comprehensive soft skills curriculum for young workers
-
LifeVantage Spokesperson, Donny Osmond, Appears on Dr. Phil
-
AFGE Launches New 'Explain it to Me, GOP' Ad Campaign
-
Arsenal Energy Inc. Releases Yearend Reserves
-
Renasant Corporation Approves Dividend
-
Travel & Adventure Show Sets Sail for Santa Clara
-
RadioShack Corporation Sets Date for Fourth-Quarter 2011 Earnings Announcement
-
SinoCoking Coal and Coke Chemical Industries to Report 2012 Second Quarter Financial Results on Friday, February 10th and Conduct Conference Call on Monday, February 13th
-
Quality Distribution, Inc. Announces Preliminary Fourth Quarter 2011 Results
-
GlobeOp Stock Purchase
-
AptarGroup Reports Record Fourth Quarter Sales and Completes Record Year
-
Aflac Incorporated to Present at the Bank of America Merrill Lynch 2012 Insurance Conference
-
Block & Leviton LLP Investigates Taleo Corporation's Board of Directors for Possible Breaches of Fiduciary Duty
-
Yorbeau Announces Appointment of Frank Di Tomaso as Director
-
Yorbeau Announces Appointment of Frank Di Tomaso as Director
-
Eurasian Minerals Extends Bronco Creek Acquisition Warrants
-
CEC Entertainment, Inc. to Webcast Fourth Quarter and Year End January 1, 2012 Earnings
-
Forward Reports Fiscal 2012 First Quarter Results
-
C.H. Robinson Worldwide Declares Quarterly Cash Dividend
-
Eurasian Minerals Extends Bronco Creek Acquisition Warrants
-
Dover Corporation Declares Regular Quarterly Cash Dividend
-
Provident Announces Updated Hedging Disclosure, the February Cash Dividend and 2011 Fourth Quarter and Year End Results Release Date and Conference Call Information
-
State AGs Coakley, Cuccinelli Lay Out Opposing Cases in Supreme Court Health Warmup
-
CBRE Clarion Global Real Estate Income Fund (NYSE: IGR) Declares Monthly Distribution for February
-
Real Estate Agent Highlights New Technologies by Bicycling 700 Miles to Mid-Winter Conference
-
Full Circle Capital Corporation Announces Second Quarter Fiscal 2012 Earnings
-
Tredegar Announces Fourth Quarter 2011 Earnings Release
-
Fortress to Release Fourth Quarter & Year End 2011 Results and Announce 2011 Fourth Quarter Dividend on February 28, 2012
-
TransCanada Pleased with Findings of Inspector General Review
-
Bicyclists Unite to Save Cycling and our Streets
-
TransCanada Pleased with Findings of Inspector General Review
